508
Participants
Start Date
November 30, 2003
Study Completion Date
March 31, 2005
Acetylsalicylic acid (Aspirin, BAYE4465)
Single Administration of 2 tablets Acetylsalicylic acid (500 mg each); in addition, 2 tablets matching placebo to Paracetamol
Paracetamol
Single Administration of 2 tablets Paracetamol (500 mg each); in addition, 2 tablets matching placebo to Acetylsalicylic Acid
Placebo
Single Administration of 2 tablets matching Placebo to Acetylsalicylic Acid together with 2 tablets matching placebo to Paracetamol
Reading
Manchester
Chorley
Wigan
Liverpool
Liverpool
Cardiff
Birmingham
Lead Sponsor
Bayer
INDUSTRY